Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Angle”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03762369
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Chong Kun Dang Pharmaceutical 384
Testing effectiveness (Phase 2)Study completedNCT03452033
What this trial is testing

H-1337 Ophthalmic Solution Phase 1/2

Who this might be right for
Glaucoma, Open-Angle
Allysta Pharmaceutical 87
Large-scale testing (Phase 3)Study completedNCT03850782
What this trial is testing

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
AbbVie 515
Large-scale testing (Phase 3)Study completedNCT01306461
What this trial is testing

Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations

Who this might be right for
Ocular HypertensionOpen-angle Glaucoma
Santen Oy 401
Large-scale testing (Phase 3)Study completedNCT05503901
What this trial is testing

A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open Angle Glaucoma, Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 131
Testing effectiveness (Phase 2)Study completedNCT05451329
What this trial is testing

Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure

Who this might be right for
Glaucoma, Open-Angle
VivaVision Biotech, Inc 68
Testing effectiveness (Phase 2)Study completedNCT02179008
What this trial is testing

Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Santen Inc. 184
Not applicableStudy completedNCT04692090
What this trial is testing

Effects of Yoga on Phase Angle and Quality of Life in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Ege University 31
Not applicableStudy completedNCT03247192
What this trial is testing

Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women

Who this might be right for
Body CompositionHealthy
Universidade Estadual de Londrina 66
Large-scale testing (Phase 3)Study completedNCT05495061
What this trial is testing

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma, Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 325
Post-approval studies (Phase 4)UnknownNCT01580254
What this trial is testing

Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma

Who this might be right for
Intraocular Pressure (IOP)Tear Break-Up Time
University of Catanzaro 120
Large-scale testing (Phase 3)Study completedNCT02565173
What this trial is testing

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma

Who this might be right for
Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Inotek Pharmaceuticals Corporation 303
Large-scale testing (Phase 3)Study completedNCT00288951
What this trial is testing

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 690
Early research (Phase 1)Not Yet RecruitingNCT06506305
What this trial is testing

Clinical Study of FB1001 in Patients

Who this might be right for
Optic NeuropathyNAION - Non-Arteritic Ischemic Optic NeuropathyAPAC - Acute Primary Angle Closure+1 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Testing effectiveness (Phase 2)Study completedNCT02742649
What this trial is testing

Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 55
Large-scale testing (Phase 3)UnknownNCT04863365
What this trial is testing

Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
pH Pharma 110
Early research (Phase 1)Study completedNCT02330978
What this trial is testing

Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.

Who this might be right for
Retinal DegenerationPrimary Open-angle Glaucoma
University of Sao Paulo 2
Testing effectiveness (Phase 2)WithdrawnNCT00855517
What this trial is testing

The Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc.
Post-approval studies (Phase 4)Ended earlyNCT04702789
What this trial is testing

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Laboratorios Sophia S.A de C.V. 28
Not applicableStudy completedNCT02023177
What this trial is testing

Phase Angle and Mortality in Patients With Cirrhosis

Who this might be right for
Malnutrition
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 249
Next Page